TipRanks
Go Ultimate55% OFF

Hansa Biopharma AB (HNSA) Balance Sheet

Hansa Biopharma AB Balance Sheet

Hansa Biopharma AB's total assets for Q2 2026 were $1.07B, a decrease of 7.86% from the previous quarter. SE:HNSA total liabilities were $1.59B for the fiscal quarter, a 10.68% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.17B$ 800.64M$ 1.02B$ 1.69B$ 1.01B
$ 1.25B$ 1.39B$ 1.19B$ 1.08B$ 255.24M
$ -84.13M$ -589.83M$ -167.88M$ 602.91M$ 757.57M

Currency in SEK

Hansa Biopharma AB Debt to Assets

0600M1.2B1.8B0 %80 %160 %240 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets